VJHemOnc Podcast

VJHemOnc Podcast

VJHemOnc

438 - Adverse events in the post-CAR T-cell therapy setting: infections, less common toxicities, and advice for physicians
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com
438 - Adverse events in the post-CAR T-cell therapy setting: infections, less common toxicities, and advice for physicians
00:00
00:00
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com

Episoade

438-

Adverse events in the post-CAR T-cell therapy setting: infections, less common toxicities, and advice for physicians

vin., 24 apr. 2026
437-

The evolving treatment landscape in MCL: chemo-free strategies, BTK inhibitors, and changing standards of care

joi, 16 apr. 2026
436-

Advances in stem cell transplantation from EBMT 2026: managing GvHD, donor selection & evolving clinical strategies

joi, 09 apr. 2026
435-

Myeloid Monthly: breaking news & updates from the classification advancement meeting

joi, 02 apr. 2026
434-

How AI is transforming hematologic oncology

vin., 27 mar. 2026